Limantrafin

CAS No.:218457-67-1

TBW04373
6-(4-(tert-Butyl)phenoxy)pyridin-3-amine;3-Pyridinamine,6-[4-(1,1-dimethylethyl)phenoxy]-;5-Amino-2-(4-tert-butylphenoxy)pyridine;6-(4-tert-butylphenoxy)pyridin-3-amine;CB-103;6-[4-(tert-butyl)phenoxy]pyridin-3-amine;Q5BB91JL0V;MLS000833648;CB103;6-(4-tert-butylphenoxy)-3-pyridinamine;SMR000457169;Maybridge1_001148;Oprea1_231562;BDBM87327;cid_2735289;GTPL10517;HMS544M04;REGID_for_CID_2735289;HMS2787I06;NSC823659;s9719;DB15279;5-Amino-2-(4-tertbutylphenoxy)pyridine;5-Amino-2-[4-(tert-butyl)phenoxy]pyridine;CCG-233915;AKOS000264357;AC-36572;CS-0109594;A815692;3-[(1H-PYRROLE-2-CARBONYL)-AMINO]PROPIONICACID;218457-67-1;Limantrafin;6-(4-(1,1-Dimethylethyl)phenoxy)-3-pyridinamine [WHO-DD];SCHEMBL4638726;FT-0620888;EX-A4302;UNII-Q5BB91JL0V;3-Pyridinamine, 6-(4-(1,1-dimethylethyl)phenoxy)-;PS-7558;HY-135145;NSC-823659;CHEMBL1420319;MFCD00052647;DTXSID00370659;6-(4-(1,1-Dimethylethyl)phenoxy)-3-pyridinamine;E80260;limantrafin [INN];[6-(4-tert-butylphenoxy)-3-pyridyl]amine
inquiry
C15H18N2O
242.32

Product introduction

Category: Drug Impurities and Intermediates
Appearance: powder
Purity: 95~98%(HPLC)
Storage conditions: -20°C under seal save, placed in ventilated, dry environment
Application: All our products are for research and lab only. Injecting, eating and other ways are forbidden.
Package: 5mg,10mg ,20mg ,50mg ,100mg,1g, 100g or customized
SMILES: O(C1C([H])=C([H])C(=C([H])N=1)N([H])[H])C1C([H])=C([H])C(=C([H])C=1[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H]